Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders

Weill Cornell Medicine (WCM)

Status: Unknown

Conditions: Gallstones; Esophageal Cancer; Bile Leak; Gastric Malignancies; Pancreatic Pseudocysts; Cholangiocarcinoma; Choledocholithiasis; Pancreatic Disorders (Noncancerous); Ampullary Cancer; Obstructive Jaundice; Biliary Strictures; Bile Duct Cancer; Acute and Chronic Pancreatitis; Pediatric Gastroenterology; Biliary and Pancreatic Stones; Cholangitis; Recurrent Pancreatitis; Bile Duct Disorders; Pancreatic Divisum; Pancreatic Cancer; Barrett's Esophagus; Colorectal Cancer; Duodenal Cancer

Treatments: Procedure: Interventional Endoscopy

Study type: Observational

Funder types: Other

Identifiers

NCT01438385

1104011642

Details and patient eligibility

About

Our institution performs therapeutic ERCP (Endoscopic retrograde cholangiopancreatography ), Endoscopic Ultrasound (EUS) and Interventional Endoscopy in around 1000 patients a year. Procedures such as biliary and/or pancreatic sphincterotomy, stents placement (metallic or plastic) and removal for revision, cysts and pseudocysts drainage are conducted in patients suffering from pancreatico-biliary disorders, gastrointestinal disorders and esophageal disorders. The investigators would like to assess prospectively the efficacy and safety of these routine procedures to permit identification of technical details about the procedures or other factors which might be associated with outcome or results. Assessment of these details would help us with problem identification and recommendations to improve health outcomes and quality of life in these patients.

Full description

Our institution performs therapeutic ERCP (Endoscopic retrograde cholangiopancreatography ), Endoscopic Ultrasound (EUS) and Interventional Endoscopy in around 1000 patients a year. Procedures such as biliary and/or pancreatic sphincterotomy, stents placement (metallic or plastic) and removal for revision, cysts and pseudocysts drainage are conducted in patients suffering from pancreatico-biliary disorders, gastrointestinal disorders and esophageal disorders. The investigators would like to assess prospectively the efficacy and safety of these routine procedures to permit identification of technical details about the procedures or other factors which might be associated with outcome or results. Assessment of these details would help us with problem identification and recommendations to improve health outcomes and quality of life in these patients.

Enrollment: 12,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Any subject that underwent Interventional Endoscopy for Pancreatico-biliary, Gastrointestinal or Esophageal disorders.
• Above the age of 18 years

Exclusion criteria

• Any group that did not undergo Interventional Endoscopy for Pancreatico-biliary, Gastrointestinal or Esophageal disorders.
• Below the age of 18 years

Trial design

12,000 participants in 1 patient group

Interventional Endoscopy

Description:

Any group that went Interventional Endoscopy procedures.

Treatment:

Procedure: Interventional Endoscopy